If you develop a side effect while taking Simponi or Simponi Aria and want to tell the FDA about it, visit MedWatch or call 800-FDA-1088. ALLERGIC REACTION For some people, Simponi or Simponi Aria ...

Simponi and Simponi Aria are prescribed to treat certain autoimmune conditions. Get the facts on financial and insurance assistance, lowering long-term costs, and more.

SIMPONI ARIA prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and SIMPONI ARIAside effects.

For Immediate Release: May 15, 2013 FDA approves Simponi to treat ulcerative colitis The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults ...

J&J subsidiary Centocor Ortho Biotech won approval from the FDA in April 2009 to market its second anti-TNF drug Simponi (golimumab) for the treatment of rheumatoid arthritis (RA), psoriatic ...

The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe ...

Johnson & Johnson’s immunology portfolio, which primarily consists of Remicade, Simponi and Stelara, accounts for around 15% of the company’s value, according to our estimates.

Simponi Aria is available as a 50mg/4mL strength solution for IV infusion; it is administered as a 30-minute infusion. For more information call (800) 526-7736 or visit SimponiAria.com.

Health Canada approves Simponi (golimumab) for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis Centocor Ortho Biotech Inc. and Schering-Plough Corporation has announced that ...

Centocor Ortho Biotech said it had filed an application with the Food and Drug Administration to get approval for Simponi (golimumab) to stop the progression of structural damage, induce major ...